SABCS

Negative Findings Show Herceptin Fails to Benefit Breast Cancer Subgroup

December 7th 2017, 12:52am

The combination use of Herceptin plus standard adjuvant chemotherapy does not improve outcomes in women with HER2-low breast cancer.

Alternative Chemotherapy Dosing Strategies Improve Breast Cancer Outcomes

December 6th 2017, 11:52pm

Article

For women with early-stage breast cancer who are receiving chemotherapy, shortening the time between treatment cycles or administering the agents sequentially may reduce disease recurrence and mortality compared with standard chemotherapy regimens.

Latest News

Understanding Treatment Sequences in Managing R/R CLL

What it Means to be Patient First in Cancer Care

A Journey Into the Unknown With My Daughter’s Aggressive Brain Cancer

T-Cell Therapy With Lete-Cel Demonstrates Efficacy in Sarcoma Subtypes

View More Latest News